| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| LLY - Eli Lilly and Company | BUY | 4,412 @ USD 837.57 | USD 3,695,359 | The ETF bought 4412 new shares of LLY (Eli Lilly and Company). The shares were bought for an average price of 837.57 compared to the previous average buy price of 843.05. This is -0.7% lower than average price of previous purchases of LLY. |
| UNH - UnitedHealth Group Incorporated | BUY | 5,154 @ USD 516.85 | USD 2,663,845 | The ETF bought 5154 new shares of UNH (UnitedHealth Group Incorporated). The shares were bought for an average price of 516.85 compared to the previous average buy price of 540.204. This is -4.3% lower than average price of previous purchases of UNH. |
| JNJ - Johnson & Johnson | BUY | 13,479 @ USD 163.63 | USD 2,205,569 | The ETF bought 13479 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 163.63 compared to the previous average buy price of 157.39. This is 4.0% higher than average price of previous purchases of JNJ. |
| ABBV - AbbVie Inc | BUY | 9,053 @ USD 210.01 | USD 1,901,221 | The ETF bought 9053 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 210.01 compared to the previous average buy price of 188.901. This is 11.2% higher than average price of previous purchases of ABBV. |
| MRK - Marks Electrical Group PLC | BUY | 14,156 @ USD 93.11 | USD 1,318,065 | The ETF bought 14156 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 93.11 compared to the previous average buy price of 94.1115. This is -1.1% lower than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 14,156 @ USD 93.11 | USD 1,318,065 | The ETF bought 14156 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 93.11 compared to the previous average buy price of 94.1115. This is -1.1% lower than average price of previous purchases of MRK. |
| ABT - Abbott Laboratories | BUY | 9,710 @ USD 126.34 | USD 1,226,761 | The ETF bought 9710 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 126.34 compared to the previous average buy price of 125.396. This is 0.8% higher than average price of previous purchases of ABT. |
| TMO - Time Out Group plc | BUY | 2,143 @ USD 517.72 | USD 1,109,474 | The ETF bought 2143 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 517.72 compared to the previous average buy price of 542.896. This is -4.6% lower than average price of previous purchases of TMO. |
| ISRG - Intuitive Surgical Inc | BUY | 2,222 @ USD 492.49 | USD 1,094,313 | The ETF bought 2222 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 492.49 compared to the previous average buy price of 563.237. This is -12.6% lower than average price of previous purchases of ISRG. |
| AMGN - Amgen Inc | BUY | 2,857 @ USD 316.04 | USD 902,926 | The ETF bought 2857 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 316.04 compared to the previous average buy price of 302.148. This is 4.6% higher than average price of previous purchases of AMGN. |
| PFE - Pfizer Inc | BUY | 31,701 @ USD 26.28 | USD 833,102 | The ETF bought 31701 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 26.28 compared to the previous average buy price of 26.2688. This is 0.0% higher than average price of previous purchases of PFE. |
| BSX - Boston Scientific Corporation | BUY | 8,242 @ USD 100.69 | USD 829,887 | The ETF bought 8242 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 100.69 compared to the previous average buy price of 97.7734. This is 3.0% higher than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 8,242 @ USD 100.69 | USD 829,887 | The ETF bought 8242 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 100.69 compared to the previous average buy price of 97.7734. This is 3.0% higher than average price of previous purchases of BSX. |
| SYK - Stryker Corporation | BUY | 2,078 @ USD 371.11 | USD 771,167 | The ETF bought 2078 new shares of SYK (Stryker Corporation). The shares were bought for an average price of 371.11 compared to the previous average buy price of 383.829. This is -3.3% lower than average price of previous purchases of SYK. |
| GILD - Guild Esports Plc | BUY | 6,970 @ USD 107.08 | USD 746,348 | The ETF bought 6970 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 107.08 compared to the previous average buy price of 100.46. This is 6.6% higher than average price of previous purchases of GILD. |
| BMY - Bloomsbury Publishing Plc | BUY | 11,875 @ USD 61.07 | USD 725,206 | The ETF bought 11875 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 61.07 compared to the previous average buy price of 57.4187. This is 6.4% higher than average price of previous purchases of BMY. |
| MDT - Medtronic PLC | BUY | 7,085 @ USD 90.33 | USD 639,988 | The ETF bought 7085 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 90.33 compared to the previous average buy price of 89.0808. This is 1.4% higher than average price of previous purchases of MDT. |
| CVS - CVS Health Corp | BUY | 8,165 @ USD 67.05 | USD 547,463 | The ETF bought 8165 new shares of CVS (CVS Health Corp). The shares were bought for an average price of 67.05 compared to the previous average buy price of 60.4705. This is 10.9% higher than average price of previous purchases of CVS. |
| DHR - Danaher Corporation | BUY | 2,436 @ USD 211.36 | USD 514,873 | The ETF bought 2436 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 211.36 compared to the previous average buy price of 223.677. This is -5.5% lower than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 2,436 @ USD 211.36 | USD 514,873 | The ETF bought 2436 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 211.36 compared to the previous average buy price of 223.677. This is -5.5% lower than average price of previous purchases of DHR. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 973 @ USD 503.2 | USD 489,614 | The ETF bought 973 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 503.2 compared to the previous average buy price of 473.058. This is 6.4% higher than average price of previous purchases of VRTX. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 696 @ USD 658.48 | USD 458,302 | The ETF bought 696 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 658.48 compared to the previous average buy price of 739.589. This is -11.0% lower than average price of previous purchases of REGN. |
| ELV - Elevance Health Inc | BUY | 875 @ USD 427.19 | USD 373,791 | The ETF bought 875 new shares of ELV (Elevance Health Inc). The shares were bought for an average price of 427.19 compared to the previous average buy price of 404.122. This is 5.7% higher than average price of previous purchases of ELV. |
| ELV - Elevance Health Inc | BUY | 875 @ USD 427.19 | USD 373,791 | The ETF bought 875 new shares of ELV (Elevance Health Inc). The shares were bought for an average price of 427.19 compared to the previous average buy price of 404.122. This is 5.7% higher than average price of previous purchases of ELV. |
| EW - Edwards Lifesciences Corp | BUY | 5,057 @ USD 70.46 | USD 356,316 | The ETF bought 5057 new shares of EW (Edwards Lifesciences Corp). The shares were bought for an average price of 70.46 compared to the previous average buy price of 71.018. This is -0.8% lower than average price of previous purchases of EW. |
| CAH - Cardinal Health Inc | BUY | 2,434 @ USD 131.89 | USD 321,020 | The ETF bought 2434 new shares of CAH (Cardinal Health Inc). The shares were bought for an average price of 131.89 compared to the previous average buy price of 124.351. This is 6.1% higher than average price of previous purchases of CAH. |
| DXCM - DexCom Inc | BUY | 4,199 @ USD 73.8 | USD 309,886 | The ETF bought 4199 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 73.8 compared to the previous average buy price of 81.6208. This is -9.6% lower than average price of previous purchases of DXCM. |
| COO - The Cooper Companies, Inc. Common Stock | BUY | 3,252 @ USD 81.71 | USD 265,721 | The ETF bought 3252 new shares of COO (The Cooper Companies, Inc. Common Stock). The shares were bought for an average price of 81.71 compared to the previous average buy price of 94.7841. This is -13.8% lower than average price of previous purchases of COO. |
| BDX - Becton Dickinson and Company | BUY | 1,092 @ USD 230.23 | USD 251,411 | The ETF bought 1092 new shares of BDX (Becton Dickinson and Company). The shares were bought for an average price of 230.23 compared to the previous average buy price of 232.028. This is -0.8% lower than average price of previous purchases of BDX. |
| GEHC - GE HealthCare Technologies Inc. | BUY | 1,722 @ USD 81.49 | USD 140,326 | The ETF bought 1722 new shares of GEHC (GE HealthCare Technologies Inc.). The shares were bought for an average price of 81.49 compared to the previous average buy price of 87.952. This is -7.3% lower than average price of previous purchases of GEHC. |
| A - Agilent Technologies Inc | BUY | 1,085 @ USD 120.75 | USD 131,014 | The ETF bought 1085 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 120.75 compared to the previous average buy price of 135.859. This is -11.1% lower than average price of previous purchases of A. |
| IDXX - IDEXX Laboratories Inc | BUY | 308 @ USD 420.99 | USD 129,665 | The ETF bought 308 new shares of IDXX (IDEXX Laboratories Inc). The shares were bought for an average price of 420.99 compared to the previous average buy price of 443.006. This is -5.0% lower than average price of previous purchases of IDXX. |
| RMD - ResMed Inc | BUY | 560 @ USD 219.7 | USD 123,032 | The ETF bought 560 new shares of RMD (ResMed Inc). The shares were bought for an average price of 219.7 compared to the previous average buy price of 238.405. This is -7.8% lower than average price of previous purchases of RMD. |
| HUM - Hummingbird Resources PLC | BUY | 455 @ USD 266.17 | USD 121,107 | The ETF bought 455 new shares of HUM (Hummingbird Resources PLC). The shares were bought for an average price of 266.17 compared to the previous average buy price of 273.886. This is -2.8% lower than average price of previous purchases of HUM. |
| HUM - Humana Inc | BUY | 455 @ USD 266.17 | USD 121,107 | The ETF bought 455 new shares of HUM (Humana Inc). The shares were bought for an average price of 266.17 compared to the previous average buy price of 273.886. This is -2.8% lower than average price of previous purchases of HUM. |
| CNC - Concurrent Technologies Plc | BUY | 1,897 @ USD 58.9 | USD 111,733 | The ETF bought 1897 new shares of CNC (Concurrent Technologies Plc). The shares were bought for an average price of 58.9 compared to the previous average buy price of 60.2693. This is -2.3% lower than average price of previous purchases of CNC. |
| MTD - Mettler-Toledo International Inc | BUY | 77 @ USD 1199.21 | USD 92,339 | The ETF bought 77 new shares of MTD (Mettler-Toledo International Inc). The shares were bought for an average price of 1199.21 compared to the previous average buy price of 1279.69. This is -6.3% lower than average price of previous purchases of MTD. |
| MTD - AMUNDI EUR GOV 710 | BUY | 77 @ USD 1199.21 | USD 92,339 | The ETF bought 77 new shares of MTD (AMUNDI EUR GOV 710). The shares were bought for an average price of 1199.21 compared to the previous average buy price of 1279.69. This is -6.3% lower than average price of previous purchases of MTD. |
| STE - STERIS plc | BUY | 378 @ USD 220.42 | USD 83,319 | The ETF bought 378 new shares of STE (STERIS plc). The shares were bought for an average price of 220.42 compared to the previous average buy price of 221.285. This is -0.4% lower than average price of previous purchases of STE. |
| ZBH - Zimmer Biomet Holdings Inc | BUY | 742 @ USD 110.73 | USD 82,162 | The ETF bought 742 new shares of ZBH (Zimmer Biomet Holdings Inc). The shares were bought for an average price of 110.73 compared to the previous average buy price of 107.05. This is 3.4% higher than average price of previous purchases of ZBH. |
| WAT - Waters Corporation | BUY | 224 @ USD 365.46 | USD 81,863 | The ETF bought 224 new shares of WAT (Waters Corporation). The shares were bought for an average price of 365.46 compared to the previous average buy price of 376.814. This is -3.0% lower than average price of previous purchases of WAT. |
| WAT - MULETFWATIMETFP | BUY | 224 @ USD 365.46 | USD 81,863 | The ETF bought 224 new shares of WAT (MULETFWATIMETFP). The shares were bought for an average price of 365.46 compared to the previous average buy price of 376.814. This is -3.0% lower than average price of previous purchases of WAT. |
| BIIB - Biogen Inc | BUY | 553 @ USD 140.9 | USD 77,918 | The ETF bought 553 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 140.9 compared to the previous average buy price of 151.1. This is -6.8% lower than average price of previous purchases of BIIB. |
| LH - Laboratory Corporation of America Holdings | BUY | 315 @ USD 234.21 | USD 73,776 | The ETF bought 315 new shares of LH (Laboratory Corporation of America Holdings). The shares were bought for an average price of 234.21 compared to the previous average buy price of 243.833. This is -3.9% lower than average price of previous purchases of LH. |
| PODD - Insulet Corporation | BUY | 266 @ USD 268.32 | USD 71,373 | The ETF bought 266 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 268.32 compared to the previous average buy price of 270.683. This is -0.9% lower than average price of previous purchases of PODD. |
| DGX - Quest Diagnostics Incorporated | BUY | 427 @ USD 167.11 | USD 71,356 | The ETF bought 427 new shares of DGX (Quest Diagnostics Incorporated). The shares were bought for an average price of 167.11 compared to the previous average buy price of 165.177. This is 1.2% higher than average price of previous purchases of DGX. |
| ZTS - Zoetis Inc | BUY | 435 @ USD 163.03 | USD 70,918 | The ETF bought 435 new shares of ZTS (Zoetis Inc). The shares were bought for an average price of 163.03 compared to the previous average buy price of 169.392. This is -3.8% lower than average price of previous purchases of ZTS. |
| BAX - Baxter International Inc | BUY | 1,911 @ USD 33.19 | USD 63,426 | The ETF bought 1911 new shares of BAX (Baxter International Inc). The shares were bought for an average price of 33.19 compared to the previous average buy price of 33.4793. This is -0.9% lower than average price of previous purchases of BAX. |
| WST - West Pharmaceutical Services Inc | BUY | 273 @ USD 228.68 | USD 62,430 | The ETF bought 273 new shares of WST (West Pharmaceutical Services Inc). The shares were bought for an average price of 228.68 compared to the previous average buy price of 274.905. This is -16.8% lower than average price of previous purchases of WST. |
| RVTY - Revvity Inc. | BUY | 469 @ USD 107.29 | USD 50,319 | The ETF bought 469 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 107.29 compared to the previous average buy price of 115.396. This is -7.0% lower than average price of previous purchases of RVTY. |
| ALGN - Align Technology Inc | BUY | 273 @ USD 168.61 | USD 46,031 | The ETF bought 273 new shares of ALGN (Align Technology Inc). The shares were bought for an average price of 168.61 compared to the previous average buy price of 195.928. This is -13.9% lower than average price of previous purchases of ALGN. |
| VTRS - Viatris Inc | BUY | 4,508 @ USD 9.15 | USD 41,248 | The ETF bought 4508 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 9.15 compared to the previous average buy price of 10.8953. This is -16.0% lower than average price of previous purchases of VTRS. |
| MRNA - Moderna Inc | BUY | 1,246 @ USD 32.66 | USD 40,694 | The ETF bought 1246 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 32.66 compared to the previous average buy price of 38.1495. This is -14.4% lower than average price of previous purchases of MRNA. |
| UHS - Universal Health Services Inc | BUY | 217 @ USD 174.14 | USD 37,788 | The ETF bought 217 new shares of UHS (Universal Health Services Inc). The shares were bought for an average price of 174.14 compared to the previous average buy price of 192.175. This is -9.4% lower than average price of previous purchases of UHS. |
| INCY - Incyte Corporation | BUY | 609 @ USD 61.92 | USD 37,709 | The ETF bought 609 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 61.92 compared to the previous average buy price of 71.3623. This is -13.2% lower than average price of previous purchases of INCY. |
| SOLV - Solventum Corp. | BUY | 504 @ USD 73.97 | USD 37,281 | The ETF bought 504 new shares of SOLV (Solventum Corp.). The shares were bought for an average price of 73.97 compared to the previous average buy price of 74.6452. This is -0.9% lower than average price of previous purchases of SOLV. |
| TECH - Bio-Techne Corp | BUY | 595 @ USD 60.61 | USD 36,063 | The ETF bought 595 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 60.61 compared to the previous average buy price of 69.1401. This is -12.3% lower than average price of previous purchases of TECH. |
| CRL - Creightons Plc | BUY | 196 @ USD 167.28 | USD 32,787 | The ETF bought 196 new shares of CRL (Creightons Plc). The shares were bought for an average price of 167.28 compared to the previous average buy price of 173.99. This is -3.9% lower than average price of previous purchases of CRL. |
| HSIC - Henry Schein Inc | BUY | 469 @ USD 69.39 | USD 32,544 | The ETF bought 469 new shares of HSIC (Henry Schein Inc). The shares were bought for an average price of 69.39 compared to the previous average buy price of 74.5864. This is -7.0% lower than average price of previous purchases of HSIC. |
| DVA - DaVita HealthCare Partners Inc | BUY | 175 @ USD 148.15 | USD 25,926 | The ETF bought 175 new shares of DVA (DaVita HealthCare Partners Inc). The shares were bought for an average price of 148.15 compared to the previous average buy price of 157.706. This is -6.1% lower than average price of previous purchases of DVA. |
| COR - Cencora Inc. | SELL | -94 @ USD 267.43 | USD -25,138 | The ETF sold 94 shares of COR on 2025-03-21. The shares were previously bought for an average price of USD 247.098. The Cencora Inc. shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 1,911 The average price that the ETF previously sold COR share for is USD 245.24 so the ETF has sold 94 shares on 2025-03-21 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -51 @ USD 661.17 | USD -33,720 | The ETF sold 51 shares of MCK on 2025-03-21. The shares were previously bought for an average price of USD 602.529. The McKesson Corporation shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 2,991 The average price that the ETF previously sold MCK share for is USD 604.074 so the ETF has sold 51 shares on 2025-03-21 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -425 @ USD 309.93 | USD -131,720 | The ETF sold 425 shares of MOH on 2025-03-21. The shares were previously bought for an average price of USD 304.806. The MOH shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 2,178 The average price that the ETF previously sold MOH share for is USD 311.386 which is higher than the selling price of USD 309.93 on 2025-03-21. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -425 @ USD 309.93 | USD -131,720 | The ETF sold 425 shares of MOH on 2025-03-21. The shares were previously bought for an average price of USD 304.806. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 2,178 The average price that the ETF previously sold MOH share for is USD 311.386 which is higher than the selling price of USD 309.93 on 2025-03-21. |
| IQV - IQVIA Holdings Inc | SELL | -1,151 @ USD 185.89 | USD -213,959 | The ETF sold 1151 shares of IQV on 2025-03-21. The shares were previously bought for an average price of USD 200.181. The IQVIA Holdings Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 16,449 The average price that the ETF previously sold IQV share for is USD 205.603 which is higher than the selling price of USD 185.89 on 2025-03-21. |
| CI - Cigna Corp | SELL | -724 @ USD 316.65 | USD -229,255 | The ETF sold 724 shares of CI on 2025-03-21. The shares were previously bought for an average price of USD 311.344. The Cigna Corp shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 3,842 The average price that the ETF previously sold CI share for is USD 322.598 which is higher than the selling price of USD 316.65 on 2025-03-21. |
| HOLX - Hologic Inc | SELL | -4,218 @ USD 61.47 | USD -259,280 | The ETF sold 4218 shares of HOLX on 2025-03-21. The shares were previously bought for an average price of USD 68.6193. The Hologic Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 30,156 The average price that the ETF previously sold HOLX share for is USD 77.6404 which is higher than the selling price of USD 61.47 on 2025-03-21. |
| HCA - HCA Holdings Inc | SELL | -798 @ USD 328.79 | USD -262,374 | The ETF sold 798 shares of HCA on 2025-03-21. The shares were previously bought for an average price of USD 334.849. The HCA Holdings Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,835 The average price that the ETF previously sold HCA share for is USD 335.641 which is higher than the selling price of USD 328.79 on 2025-03-21. |